Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus
Healthcare providers should be cautious about the increased nonalcoholic fatty liver disease risk associated with progestin-only contraceptives, especially progestin-only pills and depot medroxyprogesterone acetate. These findings could guide contraceptive options for women with a history of gestational diabetes mellitus.
Authors
- Sasiwan Suthasmalee (ORCID: https://orcid.org/0000-0002-0720-4618)
- Siriwan Tangjitgamol (ORCID: https://orcid.org/0000-0001-5367-8884)
- Chadakarn Phaloprakarn (ORCID: https://orcid.org/0000-0002-0925-2613)
- Supatsri Sethasine (ORCID: https://orcid.org/0000-0002-7637-3669)
Institutions
- Navamindradhiraj University (TH)
- Vajira Hospital (TH)
- Bangkok Hospital (TH)
Publication Details
- Journal
- Contraception
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.contraception.2025.110860
- Citations
- 6
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 12.34